World Study finds one-third of TNBC patients fail to start first-line therapy after metastatic recurrence Tomasz Wieczorek · August 4, 2026
Science Targeted drug turns stage‑4 lung cancer into 12 years of survival, clinician reports Rosalind Ashby · August 4, 2026
World
